PERSONAL STORIES // STUDY FINDINGS // WARNINGS
PT-141 Effects: What May Change and What Can Go Wrong
Sexual effects in earlier tanning work led researchers to make the drug. Later studies didn't find a large benefit, and the harms deserve your attention.
What one person's story can prove
Researchers first used PT-141 as a working name for bremelanotide. This drug copies a short body message and works mainly through your brain.
These accounts come from very different people and products. Some concern the approved drug, while others involve men or material from outside pharmacies.
A single report doesn't establish what caused a change. Nor can it tell how often that would happen to you.
Studies give firmer answers about a few harms. Blood pressure can go up for a while, and skin or gums can stay darker after frequent use.
The approved group is small and doesn't include men. I'd keep that limit in view: being left out doesn't prove harm, but safety and benefit aren't settled for you.
This page gives no dose or schedule. Even a claim told many times isn't the same as a study finding.
What people say happened after use
These are accounts from people who used material offered for lab research, not findings from a study that compared treatments. Words like "often" mean several accounts sounded alike; they don't tell you the chance of an effect.
A claim isn't firm until a proper study checks it. For now, every point below remains a personal report.
Good effects people reported
- Desire was named most: People described wanting sex again, which isn't the same as better blood flow. Several said the wish came back.
- Physical response was named often: Some people said touch brought a stronger body response, while a few felt ready for sex before anyone touched them. Others felt no change.
- Orgasm was named often: Some described orgasm as easier or better. They tied the change to stronger desire, but their accounts can't prove the cause.
- Men mentioned erections without touch: Those accounts concern an unapproved use and don't settle safety for you. No fair comparison tells you whether the accounts are right.
- Some people felt more closeness: Many others never mentioned that feeling. Closeness wasn't a main theme.
- Some effects came late and lingered: Some people liked the long span, while others couldn't judge the timing. The span differed from one account to the next.
Bad effects people reported
- Some felt no good effect: A few people had side effects with no gain. The bad effects were all they noticed.
- Nausea led the complaints: Some people called it mild, but others said they vomited. Feeling sick drove many of these accounts.
- Flushing was common in the accounts: People said the face, neck, or chest briefly felt hot or looked red. The warmth passed for many of them.
- Headache was common in the accounts: Many people mentioned head pain. They said it faded as the other early effects eased.
- Some had sore skin: People mentioned a small bump, redness, or pain near the shot. Each account covers only one person's experience.
- Some people felt tingling: A few also felt flushed or restless for a short time. Those feelings passed quickly in their accounts.
- Some felt tired or sleepy: Most described a dip on the same day. They didn't report an effect that lasted.
- Frequent use sometimes darkened color: Some people said their gums, skin, freckles, or moles stayed darker. In those accounts, the color didn't fully fade.

What the label and studies warn you about
These warnings come from studies, the US label, lab checks, and risks that remain unsettled. Some answers are firm; others are still unknown.
Check 1: Who the label includes. Anyone past menopause is outside the approved group.
To qualify, a woman's desire had been normal before it fell in every setting and caused real distress. Men aren't included, and neither are women after menopause [7][16][3].
As a man, you aren't in the approved group. That fact doesn't establish harm for all men; it tells you that your safety and benefit remain unsettled.
Check 2: Your heart and a short blood-pressure rise. A short-lived blood-pressure rise can occur, and your pulse may slow a little.
The approved medicine rules out uncontrolled high blood pressure and also rules out heart disease [7][17][18]. Tell your doctor about either problem before you weigh the drug.
Check 3: Feeling sick and vomiting. During long use, about forty percent felt sick; some vomited, and many stopped the drug [4][19][3].
That isn't a minor risk for you to brush aside. Nausea may outweigh any benefit you feel.
Check 4: Darker skin or gums. Repeated use can darken the gums, face, breasts, freckles, or moles.
The risk could be greater when your skin is dark, and the new shade might not fade [7]. You could notice that change yourself.
Check 5: Harm to the liver. A US health review found rare liver injury and small, passing rises in blood-test signs of liver irritation [20].
The review doesn't say those small rises caused lasting harm. Your own result still needs a doctor's reading.
Check 6: Material sold outside pharmacies. You can't be sure which drug is inside, how clean the vial is, or the amount inside.
Researchers tested black-market products sold for tanning or sexual effects and found unapproved drugs in them. One older case involved a related tanning drug, not bremelanotide; severe muscle damage followed, so neither report proves what's inside a vial sold under that name now [21][22].
Check 7: Hunger and body weight. A brain region involved in desire helps guide hunger too.
In short studies, some women cut their food intake and dropped weight [23][24]. The finding doesn't approve this medicine for weight loss.
Check 8: Pregnancy and breastfeeding. The risk is still unknown because no human study has answered whether pregnancy or nursing is safe.
You can't assume either group is safe. We simply don't know yet.
What PT-141 became after the first tanning tests
Early researchers tested a related drug for tanning. When sexual effects appeared, they made PT-141 and tried a nose spray in adults of both sexes.
Later studies turned to an injection for women distressed after losing desire. In June 2019, US officials approved bremelanotide for some women who were still having periods.
That tanning origin helps you see why skin may darken. It also explains how sexual effects entered the drug's history before approval [25][26][16][3][7][27][1].